One in three infected had another positive case at home
In the autumn of 2020, Portuguese researchers offered their country something official tallies could not: a true measure of how widely the virus had moved through the population. Testing more than 13,000 volunteers for antibodies, the Instituto de Medicina Molecular João Lobo Antunes found that only 1.9 percent of Portuguese carried traces of infection — a restrained figure that confirmed the first wave had been genuinely contained. Yet within that discipline, the data revealed uneven burdens: the young and urban, the essential and exposed, carried the virus more than others, and the household remained a quiet but measurable site of transmission. As families prepared to gather for the holidays, the study stood as both a testament to what had held and a warning about what might not.
- With official case counts capturing only a fraction of true infections, researchers moved to map the invisible spread — finding roughly 195,000 Portuguese had encountered the virus, three times the recorded figure.
- Young people under 18 in Lisbon and Porto showed seropositivity nearly ten times higher than rural youth, raising urgent questions about asymptomatic transmission and their role in spreading the virus to older, more vulnerable groups.
- Healthcare workers carried double the national infection rate, while retired people sheltering at home remained the most protected — a stark illustration of how exposure, not age alone, determined risk.
- Household transmission emerged as a measurable and alarming vector: 27 percent of the infected had another positive case at home, compared to just 1 percent among those who tested negative — a warning arriving precisely as Christmas gatherings loomed.
- Researchers expected seropositivity to at least double by January 2021, with the second wave already underway and longitudinal follow-up studies designed to track both antibody durability and long-term symptoms.
In the autumn of 2020, researchers at the Instituto de Medicina Molecular João Lobo Antunes recruited more than 13,000 volunteers to test for COVID-19 antibodies — seeking a truer picture of the pandemic's reach than official case counts could provide. Their finding was, in one sense, reassuring: just 1.9 percent of the Portuguese population carried antibodies, suggesting roughly 195,000 people had been infected by October, about three times the confirmed case count. Study coordinator Bruno Silva Santos described the low prevalence as formal proof that Portugal had genuinely flattened the curve during the first wave.
But the data drew sharp distinctions within that restrained national picture. Young people under 18 living in densely populated cities showed a seropositivity rate of 3.2 percent — nearly ten times higher than their rural peers. Silva Santos hypothesized that young people, often asymptomatic, may have relaxed precautions, and the data suggested they had likely become primary transmitters to other age groups. Healthcare workers, meanwhile, showed a 4 percent rate — double the national average — while retired people remaining at home proved the most protected group of all.
One finding carried particular weight as the holiday season approached: 27 percent of those who tested positive had another infected person in their household, compared to just 1 percent among those who tested negative. The message was unambiguous — domestic transmission was real, measurable, and about to become more urgent as families gathered.
The study, funded at roughly two million euros, was built to continue. Researchers planned to retest volunteers in January and track a separate group of those who had tested positive to monitor antibody durability and long-term symptoms. Asked what the next round would reveal, Silva Santos was measured: seropositivity would likely at least double, perhaps triple — but the scientist in him preferred to wait for the numbers.
In the autumn of 2020, as Portugal moved through the first wave of the pandemic, researchers at the Instituto de Medicina Molecular João Lobo Antunes set out to measure something the official case counts could not: how many people had actually encountered the virus, whether they knew it or not. They recruited more than 13,000 volunteers and tested their blood for antibodies. What they found was a portrait of a country that had, by and large, held the line.
The overall picture was stark in its restraint. Across Portugal, just 1.9 percent of the population carried antibodies to SARS-CoV-2—meaning roughly one in every fifty people had been infected by October. Extrapolated across the country, that suggested about 195,000 Portuguese had come into contact with the virus, a figure roughly three times higher than the official case count. Bruno Silva Santos, the study's coordinator, called this low prevalence "formal proof of how effectively Portugal truly flattened the curve during the first wave." It was a moment to acknowledge what had worked.
But the data also revealed sharp fault lines. Young people under eighteen living in densely populated cities—primarily Lisbon and Porto—showed a seropositivity rate of 3.2 percent, nearly ten times higher than their rural counterparts. Where the national average was one infected person per fifty, among urban youth it was closer to one per thirty. Silva Santos offered a hypothesis: young people, often asymptomatic when infected, may have felt less urgency to protect themselves, relaxing precautions they might otherwise have maintained. More troubling still, the data suggested these young urbanites had likely become the primary transmitters to other age groups.
Healthcare workers, unsurprisingly, bore a heavier burden. They showed a 4 percent seropositivity rate—double the national average—a stark reminder of their exposure on the front lines. By contrast, retired people who remained at home emerged as the most protected group, their isolation a shield against infection.
One finding carried particular weight as the holiday season approached. Among those who tested positive for antibodies, one in three had a family member also diagnosed with COVID-19. Among those who tested negative, only one in a hundred had a seropositive household member. The numbers were unambiguous: 27 percent of the infected had another positive case in their home, compared to just 1 percent among the uninfected. Household transmission was real and measurable, a warning that would soon become urgent as families gathered for Christmas.
The study also documented the disease's signature symptoms with clarity. When people reported losing their sense of smell and taste alongside fever and dry cough, those three symptoms clustered together in ways that distinguished COVID-19 from other respiratory illnesses—a pattern that emerged from the clinical surveys accompanying the blood tests.
The research, funded by the Francisco Manuel dos Santos Society and the Jerónimo Martins Group at a cost of roughly two million euros, was designed to continue. In January, researchers planned to retest two thousand volunteers who had initially tested negative, to see whether they had since encountered the virus. A separate group of three hundred who tested positive would be followed longitudinally to track the durability of their antibodies and any long-term symptoms they might develop.
When asked what he expected to find in that second round of testing, Silva Santos was cautious but clear: the seropositivity rate would likely at least double, possibly triple. That would mean more than half a million Portuguese residents carrying antibodies by winter's end. "But we will see," he said. "It is too much speculation for a scientist." What came next—the second wave, the vaccination campaign, the slow rebuilding of immunity across the population—remained to be measured.
Citações Notáveis
Formal proof of how effectively Portugal truly flattened the curve during the first wave— Bruno Silva Santos, study coordinator
Young people in densely populated cities were likely the primary transmitters to other age groups— Bruno Silva Santos
A Conversa do Hearth Outra perspectiva sobre a história
Why does a study measuring antibodies matter more than just counting confirmed cases?
Because confirmed cases only capture people sick enough to seek a test. Antibodies show everyone who was infected, including the ones who never knew they had it. In this study, the true number was three times the official count.
So young people in cities were spreading it most. Why weren't they getting sicker?
Many were asymptomatic—no fever, no cough, nothing to make them think they needed to be careful. When you feel fine, you relax. You see friends, you move through crowded places. You become a vector without knowing it.
The household transmission number is striking. One in three infected people had another positive case at home.
It shows how the virus travels where people are closest. You can control behavior in public, enforce masks and distance. But at home, with family, the guard comes down. That's where the real transmission happened.
Healthcare workers at double the national rate—was that surprising?
Not at all. They were in rooms with sick people all day. But it's worth naming: they paid a price for keeping the system running.
What does Silva Santos expect to find in January?
He thinks the numbers will at least double, maybe triple. The second wave was coming harder. He was bracing for it, but honestly, he didn't want to predict too much. Scientists know how wrong predictions can be.